8,443 reports of this reaction
2.5% of all CETIRIZINE HYDROCHLORIDE TABLETS reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for CETIRIZINE HYDROCHLORIDE TABLETS, manufactured by Dr. Reddy's Laboratories Inc.. There are 8,443 FDA adverse event reports linking CETIRIZINE HYDROCHLORIDE TABLETS to FATIGUE. This represents approximately 2.5% of all 341,923 adverse event reports for this drug.
Patients taking CETIRIZINE HYDROCHLORIDE TABLETS who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for CETIRIZINE HYDROCHLORIDE TABLETS, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for CETIRIZINE HYDROCHLORIDE TABLETS:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 8,443 FDA reports for CETIRIZINE HYDROCHLORIDE TABLETS. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.5% of all adverse event reports for CETIRIZINE HYDROCHLORIDE TABLETS, making it one of the most commonly reported side effect.
If you experience fatigue while taking CETIRIZINE HYDROCHLORIDE TABLETS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.